INSERM, UMR S953, Epidemiological Research Unit on Perinatal Health and Women's and Children's Health, Hôpital Tenon, Paris, France.
Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):183-8. doi: 10.1016/j.ejogrb.2011.04.042. Epub 2011 May 31.
In postpartum haemorrhage (PPH), as for other causes of acute haemorrhage, management can have a major impact on patient outcomes. The aim of this study was to describe critical care management, particularly transfusion practices, in cases of maternal deaths from PPH.
This retrospective study provided a descriptive analysis of all cases of maternal death from PPH in France identified through the systematic French Confidential Enquiry into Maternal Death in 2000-2003.
Thirty-eight cases of maternal death from PPH were analysed. Twenty-six women (68%) had a caesarean section [21 (55%) emergency, five (13%) elective]. Uterine atony was the most common cause of PPH (n=13, 34%). Women received a median of 9 (range 2-64) units of red blood cells (RBCs) and 9 (range 2-67) units of fresh frozen plasma (FFP). The median delay in starting blood transfusion was 82 (range 0-320)min. RBC and FFP transfusions peaked 2-4h and 12-24h after PPH diagnosis, respectively. The median FFP:RBC ratio was 0.6 (range 0-2). Fibrinogen concentrates and platelets were administered to 18 (47%) and 16 (42%) women, respectively. Three women received no blood products. Coagulation tests were performed in 20 women. The haemoglobin concentration was only measured once in seven of the 22 women who survived for more than 6h. Twenty-four women received vasopressors, a central venous access was placed in 11 women, and an invasive blood pressure device was placed in two women. General anaesthesia was administered in 37 cases, with five patients being extubated during active PPH.
This descriptive analysis of maternal deaths from PPH suggests that there may be room for improvement of specific aspects of critical care management, including: transfusion procedures, especially administration delays and FFP:RBC ratio; repeated laboratory assessments of haemostasis and haemoglobin concentration; invasive haemodynamic monitoring; and protocols for general anaesthesia.
在产后出血(PPH)中,与其他急性出血原因一样,治疗方法对患者结局有重大影响。本研究旨在描述 PPH 导致的产妇死亡病例的重症监护管理情况,尤其是输血治疗情况。
本回顾性研究对 2000-2003 年法国通过系统的全国孕产妇死亡机密性调查确定的所有 PPH 导致的产妇死亡病例进行了描述性分析。
共分析了 38 例 PPH 导致的产妇死亡病例。26 名女性(68%)接受了剖宫产术[21 例(55%)为紧急剖宫产,5 例(13%)为择期剖宫产]。子宫收缩乏力是 PPH 最常见的原因(n=13,34%)。产妇接受了中位数为 9 个单位(范围 2-64 个)红细胞(RBC)和 9 个单位(范围 2-67 个)新鲜冷冻血浆(FFP)的治疗。开始输血的中位延迟时间为 82 分钟(范围 0-320 分钟)。RBC 和 FFP 输注分别在 PPH 诊断后 2-4 小时和 12-24 小时达到高峰。FFP:RBC 比值中位数为 0.6(范围 0-2)。18 名女性(47%)和 16 名女性(42%)分别接受了纤维蛋白原浓缩物和血小板治疗。3 名女性未接受任何血液制品。20 名女性进行了凝血检测。在存活时间超过 6 小时的 22 名女性中,仅有 7 名女性仅测量了 1 次血红蛋白浓度。24 名女性接受了血管加压药治疗,11 名女性放置了中心静脉通路,2 名女性放置了有创血压装置。37 例患者接受了全身麻醉,5 例患者在 PPH 发作期间拔管。
本研究对 PPH 导致的产妇死亡病例进行了描述性分析,提示重症监护管理方面可能存在改进空间,包括:输血治疗的具体方面,尤其是输血延迟和 FFP:RBC 比值;反复评估止血和血红蛋白浓度;有创血流动力学监测;全身麻醉方案。